Clinical trial
Early and Late Effects of Nefopam in Multimodal Analgesia After Total Hip Arthroplasty (NEFARTHRO): a Multicentric Randomized Controlled Trial.
NCT06349798 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early and Late Effects of Nefopam in Multimodal Analgesia After Total Hip Arthroplasty (NEFARTHRO): a Multicentric Randomized Controlled Trial.
- Lead sponsor
- University Hospital, Tours
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- April 30, 2024
- Completion date
- April 30, 2027
- Enrollment
- 546 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
total hip arthroplasty